RATE OF FETAL LOSS AND HYDROPS FETALIS

AMONG MOTHERS AFFECTED BY PARVOVIRUS B19

Ref.	Number of cases	Fetal death	Fetal hydrops
(1) (2) (3) (4) (5) (6)	186 49 39 60 52 244	17 2 2 1 0 29	1 1 0 0 0 7
Total	630	51 (8.1%)	9 (1.4%)

REFERENCES

1. Public Health Laboratory Service Working Party on Fifth Disease. Prospective study of human parvovirus infection in pregnancy. Br Med J 1990;300:1166.
2. Centers for Disease Control: Risks associated with human parvovirus B19 infection. Morb Mortal Wkly Rep 1989;38:81.
3. Rodis JF, Quinn DL, Gary GW et.al. Management and outcome of pregnancies complicated by human parvovirus B19 infection: A prospective study. Am J Obstet Gynecol 1990;163:1168.
4. Gratacos E, Torres PJ, Vidal J et.al. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J Infect Dis 1995;171:1360.
5. Harger JH, Alder SP, Koch WC et.al. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: Risks and symptome. Obstet Gynecol 1998;91:413-420.
6. Miller E, Fairley CK, Cohen BJ et. al. Immediate and long-term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynecol 1998;105:174-178.